Work

222eP Severe immune-related adverse events with checkpoint inhibitors: A single-center experience with implications for practice

Year: 2025

Type: article

Abstract: Immune checkpoint inhibitors (ICIs) have transformed cancer treatment but cause potentially fatal immune-related adverse events (irAEs). Real-world data from resource-limited settings remain scarce. We analyzed severe irAEs incidence, management, and outcomes.

Source: Immuno-Oncology Technology

DOI: 10.1016/j.iotech.2025.101305

Authors: S. Alurkar, M.A. Vyas, V. Patel, M. Shah, S.R. Patel

Institution: HCG Cancer Centre

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $3,340